Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia

We conducted this randomized trial to investigate the efficacy and safety of rapamycin treatment in adults with chronic immune thrombocytopenia (ITP). Eighty-eight patients were separated into the control (cyclosporine A plus prednisone) and experimental (rapamycin plus prednisone) groups. The CD4+C...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaming Li, Zhaoyue Wang, Lan Dai, Lijuan Cao, Jian Su, Mingqing Zhu, Ziqiang Yu, Xia Bai, Changgeng Ruan
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/548085
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850237784163352576
author Jiaming Li
Zhaoyue Wang
Lan Dai
Lijuan Cao
Jian Su
Mingqing Zhu
Ziqiang Yu
Xia Bai
Changgeng Ruan
author_facet Jiaming Li
Zhaoyue Wang
Lan Dai
Lijuan Cao
Jian Su
Mingqing Zhu
Ziqiang Yu
Xia Bai
Changgeng Ruan
author_sort Jiaming Li
collection DOAJ
description We conducted this randomized trial to investigate the efficacy and safety of rapamycin treatment in adults with chronic immune thrombocytopenia (ITP). Eighty-eight patients were separated into the control (cyclosporine A plus prednisone) and experimental (rapamycin plus prednisone) groups. The CD4+CD25+CD127low regulatory T (Treg) cells level, Foxp3 mRNA expression, and the relevant cytokines levels were measured before and after treatment. The overall response (OR) was similar in both groups (experimental group versus control group: 58% versus 62%, P=0.70). However, sustained response (SR) was more pronounced in the experimental group than in the control group (68% versus 39%, P<0.05). Both groups showed similar incidence of adverse events (7% versus 11%, P=0.51). As expected, the low pretreatment baseline level of Treg cells was seen in all patients (P<0.001); however, the experimental group experienced a significant rise in Treg cell level, and there was a strong correlation between the levels of Treg cells and TGF-beta after the treatment. In addition, the upregulation maintained a stable level during the follow-up phase. Thus, rapamycin plus low dose prednisone could provide a new promising option for therapy of ITP.
format Article
id doaj-art-13bf02de324143d895cb4ac5f6dd23a1
institution OA Journals
issn 1740-2522
1740-2530
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-13bf02de324143d895cb4ac5f6dd23a12025-08-20T02:01:40ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/548085548085Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune ThrombocytopeniaJiaming Li0Zhaoyue Wang1Lan Dai2Lijuan Cao3Jian Su4Mingqing Zhu5Ziqiang Yu6Xia Bai7Changgeng Ruan8Key Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaKey Lab of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaWe conducted this randomized trial to investigate the efficacy and safety of rapamycin treatment in adults with chronic immune thrombocytopenia (ITP). Eighty-eight patients were separated into the control (cyclosporine A plus prednisone) and experimental (rapamycin plus prednisone) groups. The CD4+CD25+CD127low regulatory T (Treg) cells level, Foxp3 mRNA expression, and the relevant cytokines levels were measured before and after treatment. The overall response (OR) was similar in both groups (experimental group versus control group: 58% versus 62%, P=0.70). However, sustained response (SR) was more pronounced in the experimental group than in the control group (68% versus 39%, P<0.05). Both groups showed similar incidence of adverse events (7% versus 11%, P=0.51). As expected, the low pretreatment baseline level of Treg cells was seen in all patients (P<0.001); however, the experimental group experienced a significant rise in Treg cell level, and there was a strong correlation between the levels of Treg cells and TGF-beta after the treatment. In addition, the upregulation maintained a stable level during the follow-up phase. Thus, rapamycin plus low dose prednisone could provide a new promising option for therapy of ITP.http://dx.doi.org/10.1155/2013/548085
spellingShingle Jiaming Li
Zhaoyue Wang
Lan Dai
Lijuan Cao
Jian Su
Mingqing Zhu
Ziqiang Yu
Xia Bai
Changgeng Ruan
Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
Clinical and Developmental Immunology
title Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
title_full Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
title_fullStr Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
title_full_unstemmed Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
title_short Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia
title_sort effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia
url http://dx.doi.org/10.1155/2013/548085
work_keys_str_mv AT jiamingli effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT zhaoyuewang effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT landai effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT lijuancao effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT jiansu effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT mingqingzhu effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT ziqiangyu effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT xiabai effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia
AT changgengruan effectsofrapamycincombinedwithlowdoseprednisoneinpatientswithchronicimmunethrombocytopenia